Ordinary Rebalance | Solactive Global Vaccines and Infectious Diseases Index | Effective Date 15th August 2023
In the ordinary rebalance, the following index composition will be implemented effective open 15.08.2023:
3SBIO INC |
WUXI BIOLOGICS CAYMAN INC |
SK BIOSCIENCE ORD |
SHIONOGI & CO LTD ORD |
ABBOTT LABORATORIES |
ADAPTIVE BIOTECHNOLOGIES CORP |
ASTRAZENECA PLC |
BAVARIAN NORDIC A/S |
BIONTECH SE |
CATALENT INC |
CUREVAC BV |
DYNAVAX TECHNOLOGIES CORP |
GILEAD SCIENCES INC |
GENMAB A/S |
GSK PLC |
IMMUNITYBIO INC |
JOHNSON & JOHNSON |
LABORATORY CRP OF AMER HLDGS |
ELI LILLY & CO |
MERCK & CO. INC. |
MODERNA INC |
MARAVAI LIFESCIENCES HOLDINGS INC |
OPKO HEALTH INC |
VAXCYTE INC |
PFIZER INC |
REGENERON PHARMACEUTICALS |
SANOFI SA |
VIR BIOTECHNOLOGY INC |
VALNEVA SE |
ZOETIS INC |